Patent details

EP1326643 Title: INHIBITION OF EMETIC EFFECT OF METFORMIN WITH 5-HT3 RECEPTOR ANTAGONISTS

Basic Information

Publication number:
EP1326643
PCT Application Number:
PCT/US/2001/042751
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP019800200
PCT Publication Number:
WO/2002/032416
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
INHIBITION OF EMETIC EFFECT OF METFORMIN WITH 5-HT3 RECEPTOR ANTAGONISTS
French Title of Invention:
INHIBITION D'EFFET EMETIQUE DE METFORMINE AVEC DES ANTAGONISTES DU RECEPTEUR 5-HT3
German Title of Invention:
HEMMUNG DER EMETISCHEN WIRKUNG VON METFORMIN MIT 5-HT3 REZEPTOR ANTAGONISTEN
SPC Number:

Dates

Filing date:
16/10/2001
Grant date:
28/12/2005
EP Publication Date:
28/12/2005
PCT Publication Date:
25/04/2002
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
16/07/2003
EP B1 Publication Date:
28/12/2005
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
16/10/2006
Expiration date:
16/10/2021
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
16/10/2001
 
 

Name:
DepoMed Inc.
Address:
1360 O'Brien Drive, Menlo Park, CA 94025, United States (US)

Inventor

Name:
COWLES Verne, E.
Address:
United States (US)

Priority

Priority Number:
691398
Priority Date:
17/10/2000
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 45/06;
Filing date Document type Number of pages